JCB plans San Antonio factory expansion to dodge Trump’s tariffs
This post was originally published on this site The U.K.-based heavy machinery manufacturer said the levies will impact its business in the short term.
Author: Construction Dive
Jacobs lands $137M contract to manage US Virgin Islands rebuild
This post was originally published on this site The Dallas-based builder will guide the reconstruction of critical infrastructure across St. Croix, St. Thomas and St.…
Graycor hires construction vet to lead Southwest division
This post was originally published on this siteBrett Helm has spent 30 years working with large construction firms in the Phoenix area, including DPR Construction…
How location intelligence transforms construction
This post was originally published on this siteGIS technology is redefining how construction projects are planned, managed, and delivered.
Trump orders permitting agencies to embrace tech
This post was originally published on this site The president’s April 15 memo directs relevant federal agencies to submit a technology implementation plan within 45…
Industry group calls for federal action on work zone safety
This post was originally published on this site The theme for the National Work Zone Safety Awareness Week campaign, “Respect the Zone – So We…
Your contract can mitigate tariff impacts, if you know where to look
This post was originally published on this site Two construction lawyers detail how cost-plus, guaranteed maximum price and lump sum agreements work in light of…
Developers delay billions in projects amid mounting uncertainty
This post was originally published on this siteTariffs, tax credits and loan approvals are weighing upon potential builds, particularly in clean tech construction.
Tariff tensions threaten Canada’s construction market
This post was originally published on this site In response to a trade war that experts say will hurt contractors in both countries, some Canadian…
Amid tariff turmoil, Novartis commits to spending $23B on US manufacturing
This post was originally published on this site Novartis expects the new capacity will allow it to produce all of its key medicines “end to…